Testing chemo and radiation for older esophagus cancer patients
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial studies how well chemotherapy plus radiation works for people age 75 and older with esophagus cancer. It’s testing whether this treatment approach is safe and effective in an older age group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have esophagus cancer (either squamous cell or adenocarcinoma type)
- Your cancer stage is within T1 to T3, and N0 to N1 (lymph-node involvement)
- There is limited spread to the area called M1a
- You are older than 75 years
- Your overall health score is better than a “WHO 2” level
- Your kidneys and liver are working normally, and your bone marrow can make enough blood cells
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy and immunotherapy for people 65 or older with metastatic non-small cell lung cancer that has not been treated before and expresses PD-L1. It aims to see if this treatment can help control the cancer.
This trial tests whether giving chemotherapy and immunotherapy before surgery is safe and effective for older adults (70+) with a certain type of esophageal cancer. It aims to find a treatment approach that works well for patients who haven't had cancer treatment before.
This study compares a planned radiation approach given at the same time as other treatment for older adults with esophageal squamous cell carcinoma. It may help find a safer and more effective radiation schedule for people who are fit enough for treatment.
This study looks at how safe and effective a combination of immunotherapy (a treatment that helps your immune system fight cancer) and standard chemotherapy plus radiation is for older adults (70+) with a type of esophageal cancer called squamous cell carcinoma who cannot have surgery or choose not to.
This trial tests a combination of chemotherapy and immunotherapy followed by radiation for older adults with head and neck cancer. It aims to see if this approach is safe and effective for people aged 65 and older.
This trial tests adding nimotuzumab, a targeted therapy, to standard chemoradiation for elderly patients with esophageal squamous cell cancer. It aims to see if the combination improves outcomes.
Hear when a new Elderly Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.